Reid grew up in Hanover, NH and moved to Boston in 2015 for his bachelor's degree in Biology at Northeastern University. While there he worked in a lab examining the inheritance of disease resistance in termites. He also completed three internships studying Rett syndrome, sickle cell anemia, and cancer treatments utilizing neoantigen vaccines. After graduating in 2020 Reid began working Vor Biopharma utilizing CAR-T cells to treat acute myeloid leukemia.
Biography
Reserach Interest
Cancer Immunotherapies
T Cell Development
Techniques Used
Cell Line Culture, Primary cell culture, PCR, qPCR, ddPCR, Western Blot, Mouse Handling, Perfusion, IC50, Immunoprecipitation, SDS-PAGE, DNA isolation, RNA isolation, Lowry assay, BCA assay, Transfections, Transductions, Bioanalyzer RNA chips, Illumina MiSeq sequencing, 10x genomics CITE Seq
Abstracts
Publications
Poran A, Scherer J, Bushway ME, Besada R, Balogh KN, Wanamaker A, Williams RG, Prabhakara J, Ott PA, Hu-Lieskovan S, Khondker ZS, Gaynor RB, Rooney MS, Srinivasan L. Combined TCR Repertoire Profiles and Blood Cell Phenotypes Predict Melanoma Patient Response to Personalized Neoantigen Therapy plus Anti-PD-1. Cell Rep Med. 2020 Nov 17;1(8):100141. doi: 10.1016/j.xcrm.2020.100141. PMID: 33294862; PMCID: PMC7691446.
Hobbies & Extracurriculum Activities
Video games, board/card games, soccer, tennis